Breaking Research News from Breastcancer.org
Comments
-
Trodelvy Slightly Improves Overall Survival for Heavily Pre-treated Metastatic, Hormone Receptor-Positive, HER2-Negative Breast Cancer
Sep 13, 2022
The targeted therapy Trodelvy improved overall survival by 3.2 months in people diagnosed with metastatic, hormone receptor-positive, HER2-negative breast cancer that was previously treated with hormonal therapy, a CDK4/6 inhibitor, and at least two lines of chemotherapy. Read more...0 -
Hand Cooling, Compression Nearly Halve Risk of Neuropathy From Chemotherapy
Sep 15, 2022
Hand cooling and hand compression both worked well to reduce the risk of neuropathy in people receiving taxane chemotherapy for breast cancer. Read more...0 -
Why Do Some People Refuse Chemotherapy for Advanced-Stage Breast Cancer?
Sep 21, 2022
People's age, the type of health insurance they had, where they lived, and the number of other health conditions they had were all factors in their refusal to receive chemotherapy to treat advanced-stage breast cancer. Read more...0 -
New Complementary Therapy Guidelines for Cancer Pain From ASCO, SIO
Sep 21, 2022
Doctors should recommend acupuncture to ease joint pain in people taking an aromatase inhibitor to treat breast cancer, according to new guidelines from the American Society of Clinical Oncology and the Society for Integrative Oncology. Read more...0 -
Verzenio Plus Aromatase Inhibitor Improves Survival in Advanced-Stage, Hormone Receptor-Positive, HER2-Negative Breast Cancer
Sep 26, 2022
The latest results from the MONARCH 3 study show that adding Verzenio to an aromatase inhibitor improves overall survival by 12.6 months for advanced-stage, hormone receptor-positive, HER2-negative breast cancer. Read more...0 -
Response to Hormonal Therapy Before Surgery Different in Black and White Women
Sep 26, 2022
Stage I and stage II hormone receptor-positive breast cancer was more likely to shrink after hormonal therapy before surgery in Black women than in white women. But Black women had worse outcomes than white women if the breast cancer was a higher stage. Read more...0 -
Possible Link Between Inflammation, Cognitive Problems in Older Breast Cancer Survivors
Sep 30, 2022
Chronic inflammation seems related to thinking and memory problems in women age 60 and older who received breast cancer treatment. Read more...0 -
Film Bandage Helps Protect Skin During Radiation Therapy
Oct 19, 2022
A type of bandage called Mepitel Film reduced the risk of skin problems during and after radiation therapy for breast cancer. Read more...0 -
mRNA COVID-19 Vaccines Safe for Cancer Patients Receiving Immunotherapy
Oct 20, 2022
People diagnosed with cancer receiving immune checkpoint inhibitor medicines who also receive an mRNA COVID-19 vaccine don't have a greater risk of side effects from either the vaccine or the immunotherapy medicines. Read more...0 -
People With Inflammatory Breast Cancer Have High Risk of Cancer Spreading to Brain
Oct 25, 2022
People diagnosed with inflammatory breast cancer have a high risk of the cancer spreading to the brain within five years of diagnosis. Read more...0 -
COVID-19 More Deadly for Unvaccinated Cancer Patients
Oct 25, 2022
Unvaccinated people diagnosed with cancer were seven times more likely to die from any cause if they contracted COVID-19 versus if they didn't. Read more...0 -
Healthy Lifestyle May Boost Survival After Breast Cancer Diagnosis
Nov 1, 2022
Exercising regularly, maintaining a healthy weight, and eating a healthy diet may help women live longer after being diagnosed with breast cancer. Read more...0 -
Black Women Lack Access to Newer Mammogram Technology
Nov 1, 2022
Among people with Medicare, Black women had less access to newer mammogram technology than white women. Read more...0 -
Boost Dose During Accelerated Radiation Therapy Just as Effective as Conventional Schedule
Nov 2, 2022
Delivering a boost dose of radiation during an accelerated schedule decreased overall treatment time and was just as effective at reducing recurrence risk as delivering a boost dose after the final treatment of a conventional radiation schedule. Read more...0 -
Starting Exercise During Chemotherapy Helps Reduce Severity of Side Effects
Nov 4, 2022
People who started an exercise program during chemotherapy had less severe side effects and got back to regular physical functioning faster than people who started exercising after completing chemotherapy. Read more...0 -
Switching From Aromatase Inhibitor to Faslodex May Overcome Treatment Resistance
Nov 7, 2022
Switching from an aromatase inhibitor and Ibrance to Faslodex and Ibrance as the first treatment for advanced-stage, estrogen receptor-positive breast cancer seemed to overcome treatment resistance caused by ESR1 mutations. Read more...0 -
Diversity in Phase I Metastatic Cancer Drug Trials Declined From 2000 to 2018
Nov 7, 2022
Participation by American Indian or Alaska Native, Asian or Pacific Islander, Black, and Hispanic or Latin American people in phase I clinical trials for metastatic cancer drugs declined from 2000 to 2018. Read more...0 -
Acupuncture Offers Long-Term Relief for Joint Pain Caused by Aromatase Inhibitors
Nov 15, 2022
In a randomized study, acupuncture eased joint pain caused by aromatase inhibitors in women diagnosed with early-stage, hormone receptor-positive breast cancer for 40 weeks. Read more...0 -
Exercise Reduces Risk of Dying From Breast Cancer
Nov 22, 2022
Post-menopausal women with a history of early-stage disease who did even moderate exercise, such as fast walking or easy cycling, reduced their risk of dying from breast cancer. Read more...0 -
Radiation After Lumpectomy Doesn't Improve Overall Survival
Nov 22, 2022
Treating early-stage breast cancer with radiation along with chemotherapy and hormonal therapy after lumpectomy lowers recurrence risk in the same breast, but doesn't improve overall survival. Read more...0 -
Most People With Cancer Want Complementary Therapy Information Before Treatment Starts
Dec 1, 2022
Most people diagnosed with cancer in the United States want information about complementary therapies before they start receiving conventional treatment. Read more...0 -
Exercise Reduces Risk of Functional, Heart Problems Related to Chemotherapy
Dec 6, 2022
Women diagnosed with early-stage breast cancer receiving anthracycline chemotherapy who completed a 12-month exercise program had a lower risk of functional problems and better cardiovascular health. Read more...0 -
Enhertu's Benefits Confirmed for Metastatic, HER2-Positive Breast Cancer; Could Help Treat Early-Stage Disease
Dec 14, 2022
Updated results from the DESTINY-Breast02 and DESTINY-Breast03 studies confirmed the benefits of Enhertu for previously treated metastatic, HER2-positive breast cancer, and results from the TALENT trial suggest that the medicine may offer benefits for early-stage hormone receptor-positive, HER2-low breast cancer when given before surgery. Read more...0 -
Benefits of Verzenio After Surgery for Early-Stage Breast Cancer Confirmed
Dec 15, 2022
The benefits of Verzenio after surgery for early-stage, hormone receptor-positive, HER2-negative breast cancer with a high risk of recurrence were confirmed with longer follow-up. Read more...0 -
Young Women Can Safely Pause Hormonal Therapy To Attempt Pregnancy
Dec 15, 2022
Young women can safely stop hormonal therapy temporarily to try to become pregnant. Read more...0 -
Kisqali Plus Hormonal Therapy More Effective Than Chemotherapy as First Treatment for Advanced-Stage Breast Cancer
Dec 19, 2022
Pre-menopausal women diagnosed with advanced-stage, hormone receptor-positive, HER2-negative breast cancer got more benefits from Kisqali and hormonal therapy than chemotherapy as a first treatment. Read more...0 -
Updated TAILORx Results Confirm Women With Intermediate Recurrence Score Can Skip Chemotherapy
Dec 19, 2022
Four more years of follow-up continue to show that women with an Oncotype DX Breast Recurrence Score of 11-25 can safely skip chemotherapy; their risk or recurrence wasn't higher than women who received chemotherapy. Read more...0 -
Mammogram Travel Time Still Long for Many U.S. Women
Dec 19, 2022
Travel time to the nearest mammography center is long for many U.S. women, especially women in rural areas. Read more...0 -
Why Don't Chemotherapy-Resistant Breast Cancers Respond to Immunotherapy?
Dec 22, 2022
Early research hints at why breast cancer cells that survive chemotherapy also don't respond to immunotherapy. Read more...0 -
New Guidelines on Treating High Calcium Levels in People With Cancer
Jan 4, 2023
The Endocrine Society has released the first guidelines on treating high calcium levels in people diagnosed with cancer. Read more...0
